Journal Home
Search for

Volume 89, Issue 1, Pages 24-30 (January 2008)


View previous. 9 of 41 View next.

Cost-Effectiveness of C-Leg Compared With Non–Microprocessor-Controlled Knees: A Modeling Approach

Thor-Henrik Brodtkorb, MS, CPOabCorresponding Author Informationemail address, Martin Henriksson, MSa, Kasper Johannesen-Munk, CPOb, Fredrik Thidell, CPOb

Abstract 

Brodtkorb T-H, Henriksson M, Johannesen-Munk K, Thidell F. Cost-effectiveness of C-Leg compared with non–microprocessor-controlled knees: a modeling approach.

Objective

To estimate the costs and health outcomes of C-Leg and non–microprocessor-controlled (NMC) knees using a decision-analytic model.

Design

Data on costs, rates and duration of problems, knee survival, and health-related quality of life were obtained from interviews with patients and prosthetists with experience of both C-Leg and NMC knees. Interview data were assessed in a decision-analytic Markov model to estimate cost-effectiveness from a health care perspective.

Setting

Outpatient.

Participants

A population sample of 20 patients currently using the C-Leg and prior experience of nonmicroprocessor knees, and 5 prosthetists.

Interventions

Not applicable.

Main Outcome Measure

Incremental cost per quality-adjusted life year (QALY).

Results

The mean incremental cost (in 2006 Euros) and QALYs for the C-Leg was €7657 and 2.38, respectively, yielding a cost per QALY gained of €3218.

Conclusions

It is important to provide decision-makers with relevant information on costs and health outcomes of different treatment strategies on actual decision problems despite limited evidence. The results of the study, taking into account both costs and a broadly defined health outcome in terms of QALY, show that given existing albeit limited evidence the C-Leg appears to yield positive health outcomes at an acceptable cost.

a Center for Medical Technology Assessment, Department of Medicine and Health Sciences, Linköpings Universitet, Linköping, Sweden

b Department of Rehabilitation, School of Health Sciences, Jönköping University, Jönköping, Sweden.

Corresponding Author InformationReprint requests to Thor-Henrik Brodtkorb, MS, CPO, Center for Medical Technology Assessment, Dept of Medicine and Health Sciences, Linköpings Universitet, Linköping, Sweden, SE-81 83

 A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit upon the author or 1 or more of the authors. Johannesen-Munk and Thidell received financial support from Otto Bock for travel expenses associated with data collection. Brodtkorb has been a consultant to Otto Bock and competing prosthetic manufacturers.

PII: S0003-9993(07)01596-1

doi:10.1016/j.apmr.2007.07.049


View previous. 9 of 41 View next.